US Patent No: 5,548,065

Number of patents in Portfolio can not be more than 2000

Tyrosine kinase receptor human flk-2-specific antibodies

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

Isolated mammalian nucleic acid molecules encoding receptor protein tyrosine kinases expressed in primitive hematopoietic cells and not expressed in mature hematopoietic cells are provided. Also included are the receptors encoded by such nucleic acid molecules; the nucleic acid molecules encoding receptor protein tyrosine kinases having the sequences shown in FIG. 1a (murine flk-2), FIG. 1b (human flk-2) and FIG. 2 (murine flk-1); the receptor protein tyrosine kinases having the amino acid sequences shown in FIG. 1a, FIG. 1b and FIG. 2; ligands for the receptors; nucleic acid sequences that encode the ligands; and methods of stimulating the proliferation and/or differentiation of primitive mammalian hematopoietic stem cells comprising contacting the stem cells with a ligand that binds to a receptor protein tyrosine kinase expressed in primitive mammalian hematopoietic cells and not expressed in mature hematopoietic cells.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PRINCETON UNIVERSITYPRINCETON, NJ619

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lemischka, Ihor R Princeton, NJ 15 250

Cited Art

Patent Info (Count) # Cites Year
 
PRINCETON UNIVERSITY (4)
5,185,438 Nucleic acids encoding hencatoporetic stem cell receptor flk-2 66 1991
5,283,354 Nucleic acids encoding hematopoietic stem cells receptors flk-1 56 1992
5,270,458 Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2 51 1992
5,367,057 Tyrosine kinase receptor flk-2 and fragments thereof 22 1993
 
NOVARTIS AG (1)
5,061,620 Human hematopoietic stem cell 216 1990

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
CELLDEX THERAPEUTICS, INC. (6)
6,632,424 Human FLTS3 ligand 1 1995
5,843,423 Methods of stimulating hematopoietic cells with flt3-ligand 47 1997
6,190,655 Methods of using Flt-3 ligand for exogenous gene transfer 12 1998
7,041,282 Ligands for flt3 receptors 0 2001
7,361,330 Methods of using flt3-ligand in the treatment of fibrosarcoma 0 2002
7,294,331 Methods of using flt3-ligand in hematopoietic cell transplantation 0 2002
 
IMCLONE LLC (3)
7,498,414 Human antibodies specific to KDR and uses thereof 1 2003
7,972,596 Antibodies against vascular endothelial growth factor receptor-1 0 2005
8,071,099 Anti-FLT3 antibodies 0 2010
 
IMCLONE SYSTEMS INCORPORATED (2)
6,448,077 Chimeric and humanized monoclonal antibodies specific to VEGF receptors 6 1997
6,811,779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy 10 2001
 
INNUNEX CORPORATION (1)
7,150,992 Methods of preparing dendritic cells with flt3-ligand and antigen 0 2000
 
MAKAROVSKY, ANDREW N. (1)
6,632,620 Compositions for identification and isolation of stem cells 7 2000
 
MARAKOVSKIY, ANDREW N. (1)
7,223,549 Compositions for identification and isolation of stem cells 0 2002
 
PRINCETON UNIVERSITY (1)
7,465,464 Populations of cells that express flk-2 receptors 0 2005
 
RHODE ISLAND HOSPITAL (1)
6,129,911 Liver stem cell 32 1998
 
SIEMENS VDO AUTOMOTIVE CORPORATION (1)
6,921,021 Spray pattern control with non-angled orifices formed on a dimpled fuel injection metering disc having a sac volume reducer 2 2004
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (1)
5,997,865 Agonist antibodies against the flk2/flt3 receptor and uses thereof 11 1995